A Bayesian‐Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma
Authors:
- Lin XuLin Xu
- Arhanti SadanandASArhanti Sadanand
- Evan W. NeczyporENEvan W. Neczypor
- Yen‐Ting LiuYLYen‐Ting Liu
- Erin ButlerEBErin Butler
- Kelley MooreKMKelley Moore
- Flannery BowmanFBFlannery Bowman
- Yamin MazumderYMYamin Mazumder
- Arlene NaranjoANArlene Naranjo
- Alexandre ChlenskiACAlexandre Chlenski
- Xue XiaoXXXue Xiao
- Lei GuoLGLei Guo
Open Access
- 10 June 2026
- journal article
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (6) , e70627
Abstract
Identifying targetable oncogenic drivers remains a challenge in neuroblastoma, the most common extracranial solid malignancy in children. We applied a Bayesian algorithm for integrative analysis of expression and copy‐number, iExCN, to nominate oncogenic drivers in neuroblastoma. The iExCN algorithm found 47 oncogenes from a dataset of 195 neuroblastoma biopsy specimens. The nominated oncogenes included some previously implicated in neuroblastoma, including ALK , MDM2 , MYCN , and XPO1 , but most have not been linked to this disease. A CRISPR/Cas9‐based screen testing those candidates revealed neuroblastoma cell line‐specific and shared vulnerabilities in three well‐characterized models, and dependencies were confirmed by complementary RNA knockdown. Analysis of more than 30 additional neuroblastoma cell lines using DepMap confirmed statistically significant dependency scores in the iExCN genes. Finally, analysis of two cohorts of children with neuroblastoma revealed a trend toward worse survival in cases in which more iExCN genes showed copy number gains. Our findings uncover multiple, potentially targetable oncogenic drivers that appear to influence neuroblastoma biology, demonstrating a generalizable capacity for iExCN to unmask disease genes and therapeutic targets in cancer.Keywords
This publication has 57 references indexed in Scilit:
- Accumulation of Segmental Alterations Determines Progression in NeuroblastomaJournal of Clinical Oncology, 2010
- Overall Genomic Pattern Is a Predictor of Outcome in NeuroblastomaJournal of Clinical Oncology, 2009
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008
- Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expressionGenes, Chromosomes and Cancer, 2007
- NeuroblastomaThe Lancet, 2007
- Chromosome 1p and 11q Deletions and Outcome in NeuroblastomaNew England Journal of Medicine, 2005
- Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastomaOncogene, 2001
- Molecular Biology of NeuroblastomaJournal of Clinical Oncology, 1999
- Gain of Chromosome Arm 17q and Adverse Outcome in Patients with NeuroblastomaNew England Journal of Medicine, 1999
- MYCN Is the only highly expressed gene from the core amplified domain in human neuroblastomasGenes, Chromosomes and Cancer, 1998